Xbrane Biopharma AB(DE:7XB0)
€0.95-0.06 (-5.54%)
DE:7XB0
Xbrane Biopharma AB Revenue
€0.95
At close:-0.06 (-5.54%)
Xbrane Biopharma AB (7XB0) Revenue
6 Followers
Xbrane Biopharma AB Revenue
Xbrane Biopharma AB had a revenue of 54.77M in the quarter ending Sep 30, 2026, with 17.16%. This bring the company's revenue in the last twelve months to 127.95M, Increased 53.61%. In the fiscal year ending Dec 31, 2025, Xbrane Biopharma AB had annual revenue of 152.35M with -23.32% growth.
- Revenue (ttm)
- 127.95M
- Revenue Growth
- -37.13%
- P/S Ratio
- 0.14
- Revenue/Employee
- EUR 5,441,214
- Employees
- 28
- Market Cap
- EUR 21.24M
Revenue Chart
Xbrane Biopharma AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 152.35M | -46.35M | -23.32% |
| Dec 31, 2024 | 198.70M | -40.03M | -16.77% |
| Dec 31, 2023 | 238.73M | 181.11M | 314.33% |
| Dec 31, 2022 | 57.62M | 46.09M | 399.59% |
| Dec 31, 2021 | 11.53M | 4.71M | 69.08% |
| Dec 31, 2020 | 6.82M | 6.22M | 1036.83% |
| Dec 31, 2019 | 600.00K | -112.35M | -99.47% |
| Dec 31, 2018 | 112.95M | 92.18M | 443.80% |
| Dec 31, 2017 | 20.77M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.